The high expression of TGFBR2 was an important risk factor for the diminishing of OS and disease-free survival (DFS) in NSCLC patients [38], and the P value of the prognostic value of TGFBR2 based on the Kaplan-Meier Plotter was also <0.05, which suggests that there was a tight relationship between the expression of TGFBR2 and the prognosis of LUAD patients. Here, TGFBR2 is linked to non-small cell lung carcinoma.